Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe ...

This latest evolution will integrate several unique ... For customers with products in glass-barrel syringes, this new closure will be an opportunity to integrate gold-standard Luer Lock features ...

This latest evolution will integrate several unique technical advances guided by both shifting ... For customers with products in glass-barrel syringes, this new closure will be an opportunity to ...

Friendly germs armed with their own biological syringes and poisons could hold ... a highly valuable property—they limit resistance evolution to T6SS attacks. In both computer simulations ...

Ravensburg, January 14, 2025 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its ...

© Vetter Pharma International GmbH: Vetter's new V-OVS® next syringe closure system integrates valuable real-world insights and customer feedback to set a new ...